Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2/HO‑1 axis

Wu,Wenqing; Peng,Ge; Yang,Fan; Zhang,Yue; Mu,Zhenzhen; Han,Xiuping

doi:10.3892/mmr.2019.10405

Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2/HO‑1 axis

Authors:
- Wenqing Wu
- Ge Peng
- Fan Yang
- Yue Zhang
- Zhenzhen Mu
- Xiuping Han
View Affiliations

Affiliations: Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Atopy (Allergy) Research Center, Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo 1138642, Japan
Published online on: June 20, 2019 https://doi.org/10.3892/mmr.2019.10405
Pages: 1761-1771
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atopic dermatitis (AD), a chronic inflammatory skin disease, is characterized by intense itching and recurrent eczematous lesions. Sulforaphane is known to attenuate oxidative stress, and tissue or cell damage in cerebral ischemia, brain inflammation and intracerebral hemorrhage. In the present study, a 2,4‑dinitrochlorobenzene (DNCB)‑induced AD mouse model was developed, and ear thickness, dermatitis score, eosinophil count, mast cell infiltration, and serum IgE levels were measured in DNCB‑induced AD and sulforaphane‑treated groups to demonstrate the therapeutic effects of sulforaphane. AD symptoms of DNCB‑induced mice were attenuated by sulforaphane treatment compared with those of negative control mice; furthermore, eosinophil count, mast cell infiltration and serum IgE levels were also reduced by sulforaphane treatment in DNCB‑induced AD mice. Western blot assays revealed that the expression levels of nuclear factor‑E2‑related factor 2 (Nrf2) and heme oxygenase-1 (HO‑1), which exhibit oxidation resistance, were increased by sulforaphane treatment in DNCB‑induced AD mice. The present study suggested that sulforaphane exerted a therapeutic effect in the AD mouse model through the activation of the Nrf2/HO‑1 axis as well as the suppression of Janus kinase 1/STAT3 signaling pathway.

View Figures

View References

1	Bieber T: Atopic dermatitis. N Engl J Med. 358:1483–1494. 2008. View Article : Google Scholar : PubMed/NCBI
2	Weidinger S and Novak N: Atopic dermatitis. Lancet. 387:1109–1122. 2016. View Article : Google Scholar : PubMed/NCBI
3	Werfel T, Schwerk N, Hansen G and Kapp A: The diagnosis and graded therapy of atopic dermatitis. Dtsch Arztebl Int. 111:509–520. 2014.PubMed/NCBI
4	Gęgotek A and Skrzydlewska E: The role of transcription factor Nrf2 in skin cells metabolism. Arch Dermatol Res. 307:385–396. 2015. View Article : Google Scholar : PubMed/NCBI
5	Ji H and Li XK: Oxidative stress in atopic dermatitis. Oxid Med Cell Longev. 2016:27214692016. View Article : Google Scholar : PubMed/NCBI
6	Rojo de la Vega M, Krajisnik A, Zhang DD and Wondrak GT: Targeting NRF2 for improved skin barrier function and photoprotection: Focus on the achiote-derived apocarotenoid bixin. Nutrients. 9:E13712017. View Article : Google Scholar : PubMed/NCBI
7	Gruber F, Ornelas CM, Karner S, Narzt MS, Nagelreiter IM, Gschwandtner M, Bochkov V and Tschachler E: Nrf2 deficiency causes lipid oxidation, inflammation and matrix-protease expression in DHA supplemented and UVA irradiated skin fibroblasts. Free Radic Biol Med. 88:439–451. 2015. View Article : Google Scholar : PubMed/NCBI
8	Guerrero-Beltrán CE, Calderón-Oliver M, Pedraza-Chaverri J and Chirino YI: Protective effect of sulforaphane against oxidative stress: Recent advances. Exp Toxicol Pathol. 64:503–508. 2012. View Article : Google Scholar : PubMed/NCBI
9	Mathew ST, Bergström P and Hammarsten O: Repeated Nrf2 stimulation using sulforaphane protects fibroblasts from ionizing radiation. Toxicol Appl Pharmacol. 276:188–194. 2014. View Article : Google Scholar : PubMed/NCBI
10	Kumar KJ, Yang HL, Tsai YC, Hung PC, Chang SH, Lo HW, Shen PC, Chen SC, Wang HM, Wang SY, et al: Lucidone protects human skin keratinocytes against free radical-induced oxidative damage and inflammation through the up-regulation of HO-1/Nrf2 antioxidant genes and down-regulation of NF-κB signaling pathway. Food Chem Toxicol. 59:55–66. 2013. View Article : Google Scholar : PubMed/NCBI
11	Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T and Kadono T: Atopic dermatitis: Immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int. 66:398–403. 2017. View Article : Google Scholar : PubMed/NCBI
12	Kiiski V, Karlsson O, Remitz A and Reitamo S: High serum total IgE predicts poor long-term outcome in atopic dermatitis. Acta Derm Venereol. 95:943–947. 2015. View Article : Google Scholar : PubMed/NCBI
13	Lucae S, Schmid-Grendelmeier P, Wüthrich B, Kraft D, Valenta R and Linhart B: IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment. Allergy. 71:115–118. 2016. View Article : Google Scholar : PubMed/NCBI
14	Altrichter S, Kriehuber E, Moser J, Valenta R, Kopp T and Stingl G: Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J Invest Dermatol. 128:2232–2239. 2008. View Article : Google Scholar : PubMed/NCBI
15	Liu FT, Goodarzi H and Chen HY: IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol. 41:298–310. 2011. View Article : Google Scholar : PubMed/NCBI
16	Elovic A, Wong DT, Weller PF, Matossian K and Galli SJ: Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol. 93:864–869. 1994. View Article : Google Scholar : PubMed/NCBI
17	Kato A, Chustz RT, Ogasawara T, Kulka M, Saito H, Schleimer RP and Matsumoto K: Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells. J Immunol. 182:7233–7243. 2009. View Article : Google Scholar : PubMed/NCBI
18	Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Wu J, Ushida Y, Suganuma H and Hashimoto K: Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation. J Nutr Biochem. 39:134–144. 2017. View Article : Google Scholar : PubMed/NCBI
19	Yan B, Ma Z, Shi S, Hu Y, Ma T, Rong G and Yang J: Sulforaphane prevents bleomycin-induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2-related factor-2 activation. Mol Med Rep. 15:4005–4014. 2017. View Article : Google Scholar : PubMed/NCBI
20	O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, Kelley KW and Dantzer R: Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry. 14:511–522. 2009. View Article : Google Scholar : PubMed/NCBI
21	Peng G, Mu Z, Cui L, Liu P, Wang Y, Wu W and Han X: Anti-IL-33 antibody has a therapeutic effect in an atopic dermatitis murine model induced by 2, 4-dinitrochlorobenzene. Inflammation. 41:154–163. 2018. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	David Boothe W, Tarbox JA and Tarbox MB: Atopic dermatitis: Pathophysiology. Adv Exp Med Biol. 1027:21–37. 2017. View Article : Google Scholar : PubMed/NCBI
24	Briganti S and Picardo M: Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol. 17:663–669. 2010. View Article : Google Scholar
25	Yang L, Palliyaguru DL and Kensler TW: Frugal chemoprevention: Targeting Nrf2 with foods rich in sulforaphane. Semin Oncol. 43:146–153. 2016. View Article : Google Scholar : PubMed/NCBI
26	Ruiz S, Pergola PE, Zager RA and Vaziri ND: Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 83:1029–1041. 2013. View Article : Google Scholar : PubMed/NCBI
27	Lawal AO: Air particulate matter induced oxidative stress and inflammation in cardiovascular disease and atherosclerosis: The role of Nrf2 and AhR-mediated pathways. Toxicol Lett. 270:88–95. 2017. View Article : Google Scholar : PubMed/NCBI
28	Prasad KN: Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease. Mech Ageing Dev. 153:41–47. 2016. View Article : Google Scholar : PubMed/NCBI
29	Schäfer M, Farwanah H, Willrodt AH, Huebner AJ, Sandhoff K, Roop D, Hohl D, Bloch W and Werner S: Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med. 4:364–379. 2012. View Article : Google Scholar : PubMed/NCBI
30	Choi JH, Jin SW, Han EH, Park BH, Kim HG, Khanal T, Hwang YP, Do MT, Lee HS, Chung YC, et al: Platycodon grandiflorum root-derived saponins attenuate atopic dermatitis-like skin lesions via suppression of NF-κB and STAT1 and activation of Nrf2/ARE-mediated heme oxygenase-1. Phytomedicine. 21:1053–1061. 2014. View Article : Google Scholar : PubMed/NCBI
31	Saw CL, Huang MT, Liu Y, Khor TO, Conney AH and Kong AN: Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane. Mol Carcinog. 50:479–486. 2011. View Article : Google Scholar : PubMed/NCBI
32	Chaiprasongsuk A, Lohakul J, Soontrapa K, Sampattavanich S, Akarasereenont P and Panich U: Activation of Nrf2 reduces UVA-mediated MMP-1 upregulation via MAPK/AP-1 signaling cascades: The photoprotective effects of sulforaphane and hispidulin. J Pharmacol Exp Ther. 360:388–398. 2017. View Article : Google Scholar : PubMed/NCBI
33	Migdal C, Botton J, El Ali Z, Azoury ME, Guldemann J, Giménez-Arnau E, Lepoittevin JP, Kerdine-Römer S and Pallardy M: Reactivity of chemical sensitizers toward amino acids in cellulo plays a role in the activation of the Nrf2-ARE pathway in human monocyte dendritic cells and the THP-1 cell line. Toxicol Sci. 133:259–274. 2013. View Article : Google Scholar : PubMed/NCBI
34	Emter R, van der Veen JW, Adamson G, Ezendam J, van Loveren H and Natsch A: Gene expression changes induced by skin sensitizers in the KeratinoSens™ cell line: Discriminating Nrf2-dependent and Nrf2-independent events. Toxicol In Vitro. 27:2225–2232. 2013. View Article : Google Scholar : PubMed/NCBI
35	Welsch K, Holstein J, Laurence A and Ghoreschi K: Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors. Eur J Immunol. 47:1096–1107. 2017. View Article : Google Scholar : PubMed/NCBI
36	Jin W, Huang W, Chen L, Jin M, Wang Q, Gao Z and Jin Z: Topical application of JAK1/JAK2 inhibitor momelotinib exhibits significant anti-inflammatory responses in DNCB-induced atopic dermatitis model mice. Int J Mol Sci. 19:E39732018. View Article : Google Scholar : PubMed/NCBI
37	Abe Y and Tanaka N: The Hedgehog signaling networks in lung cancer: The mechanisms and roles in tumor progression and implications for cancer therapy. Biomed Res Int. 2016:79692862016. View Article : Google Scholar : PubMed/NCBI
38	Chu J, Wang X, Bi H, Li L, Ren M and Wang J: Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid arthritis model. Int Immunopharmacol. 59:174–180. 2018. View Article : Google Scholar : PubMed/NCBI
39	Roy R, Dagher A, Butterfield C and Moses MA: ADAM12 is a novel regulator of tumor angiogenesis via STAT3 signaling. Mol Cancer Res. 15:1608–1622. 2017. View Article : Google Scholar : PubMed/NCBI
40	Choi JK, Jang YH, Lee S, Lee SR, Choi YA, Jin M, Choi JH, Park JH, Park PH, Choi H, et al: Chrysin attenuates atopic dermatitis by suppressing inflammation of keratinocytes. Food Chem Toxicol. 110:142–150. 2017. View Article : Google Scholar : PubMed/NCBI
41	Pastore S, Giustizieri ML, Mascia F, Giannetti A, Kaushansky K and Girolomoni G: Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. J Invest Dermatol. 115:1134–1143. 2000. View Article : Google Scholar : PubMed/NCBI
42	Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R and Sarfati M: Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol. 136:351–359.e1. 2015. View Article : Google Scholar : PubMed/NCBI
43	Mu Z, Zhao Y, Liu X, Chang C and Zhang J: Molecular biology of atopic dermatitis. Clin Rev Allergy Immunol. 47:193–218. 2014. View Article : Google Scholar : PubMed/NCBI
44	Matsushima M, Takagi K, Ogawa M, Hirose E, Ota Y, Abe F, Baba K, Hasegawa T, Hasegawa Y and Kawabe T: Heme oxygenase-1 mediates the anti-allergic actions of quercetin in rodent mast cells. Inflammation Res. 58:705–715. 2009. View Article : Google Scholar
45	Ma YY, Yang MQ, Wang CF, Ding J and Li JY: Inhibiting mast cell degranulation by HO-1 affects dendritic cell maturation in vitro. Inflamm Res. 63:527–537. 2014. View Article : Google Scholar : PubMed/NCBI
46	Zink A, Gensbaur A, Zirbs M, Seifert F, Suarez IL, Mourantchanian V, Weidinger S, Mempel M, Ring J and Ollert M: Targeting IgE in severe atopic dermatitis with a combination of immunoadsorption and omalizumab. Acta Derm Venereol. 96:72–76. 2016. View Article : Google Scholar : PubMed/NCBI
47	Park G, Oh DS, Lee MG, Lee CE and Kim YU: 6-Shogaol, an active compound of ginger, alleviates allergic dermatitis-like skin lesions via cytokine inhibition by activating the Nrf2 pathway. Toxicol Appl Pharmacol. 310:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
48	Kiehl P, Falkenberg K, Vogelbruch M and Kapp A: Tissue eosinophilia in acute and chronic atopic dermatitis: A morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol. 145:720–729. 2001. View Article : Google Scholar : PubMed/NCBI
49	Ajith Y, Dimri U, Gopalakrishnan A, Madhesh E, Jhambh R, Joshi V and Devi G: Th1/Th2 immune responses and oxidative stress in caprine flea allergy dermatitis. Parasite Immunol. 39:2017. View Article : Google Scholar : PubMed/NCBI
50	Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, et al: Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 138:336–349. 2016. View Article : Google Scholar : PubMed/NCBI